XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2021   355,400,000        
Beginning balance at Dec. 31, 2021 $ 5,706.2 $ 3.6 $ 2,717.6 $ 2,805.3 $ (247.5) $ 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (2,400,000) (2,400,000)        
Shares repurchased $ (105.3)     (105.3)    
Equity-based compensation $ 85.0   85.0      
Shares issued for equity-based awards (in shares)   3,300,000        
Shares issued for performance allocations (in shares) 771,157 700,000        
Shares issued for performance allocations $ 36.5   36.5      
Shares issued related to the acquisition of CBAM (in shares)   4,200,000        
Shares issued related to the acquisition of CBAM 194.5   194.5      
Contributions 166.9         166.9
Dividends and distributions (363.7)     (207.1)   (156.6)
Net income (loss) 843.7     817.0   26.7
Currency translation adjustments (127.5)       (109.3) (18.2)
Defined benefit plans, net (4.0)       (4.0)  
Ending balance (in shares) at Jun. 30, 2022   361,200,000        
Ending balance at Jun. 30, 2022 6,432.3 $ 3.6 3,033.6 3,309.9 (360.8) 446.0
Beginning balance (in shares) at Mar. 31, 2022   361,700,000        
Beginning balance at Mar. 31, 2022 6,354.3 $ 3.6 2,982.4 3,207.0 (283.0) 444.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares)   (700,000)        
Shares repurchased (24.9)     (24.9)    
Equity-based compensation $ 46.0   46.0      
Shares issued for equity-based awards (in shares)   100,000        
Shares issued for performance allocations (in shares) 134,696 100,000        
Shares issued for performance allocations $ 5.2   5.2      
Contributions 20.1         20.1
Dividends and distributions (127.1)     (117.6)   (9.5)
Net income (loss) 248.9     245.4   3.5
Currency translation adjustments (87.7)       (75.3) (12.4)
Defined benefit plans, net (2.5)       (2.5)  
Ending balance (in shares) at Jun. 30, 2022   361,200,000        
Ending balance at Jun. 30, 2022 $ 6,432.3 $ 3.6 3,033.6 3,309.9 (360.8) 446.0
Beginning balance (in shares) at Dec. 31, 2022 362,298,650 362,300,000        
Beginning balance at Dec. 31, 2022 $ 6,821.3 $ 3.6 3,138.5 3,401.1 (322.2) 600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (5,200,000) (5,200,000)        
Shares repurchased $ (160.8)     (160.8)    
Equity-based compensation 123.4   123.4      
Shares issued for equity-based awards (in shares)   2,900,000        
Dividend-equivalent rights on certain equity-based awards 0.0   4.6 (4.6)    
Deconsolidation of Consolidated Entities $ (7.1)         (7.1)
Shares issued for performance allocations (in shares) 0          
Contributions $ 55.5         55.5
Dividends and distributions (279.2)     (245.1)   (34.1)
Net income (loss) 62.6     2.3   60.3
Currency translation adjustments 29.0       23.0 6.0
Defined benefit plans, net $ (0.1)       (0.1)  
Ending balance (in shares) at Jun. 30, 2023 359,952,112 360,000,000.0        
Ending balance at Jun. 30, 2023 $ 6,644.6 $ 3.6 3,266.5 2,992.9 (299.3) 680.9
Beginning balance (in shares) at Mar. 31, 2023   362,100,000        
Beginning balance at Mar. 31, 2023 6,811.5 $ 3.6 3,195.5 3,280.9 (305.2) 636.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares)   (2,200,000)        
Shares repurchased (60.5)     (60.5)    
Equity-based compensation 68.6   68.6      
Shares issued for equity-based awards (in shares)   100,000        
Dividend-equivalent rights on certain equity-based awards 0.0   2.4 (2.4)    
Deconsolidation of Consolidated Entities $ (7.1)         (7.1)
Shares issued for performance allocations (in shares) 0          
Contributions $ 36.8         36.8
Dividends and distributions (150.9)     (126.7)   (24.2)
Net income (loss) (62.7)     (98.4)   35.7
Currency translation adjustments 9.2       6.2 3.0
Defined benefit plans, net $ (0.3)       (0.3)  
Ending balance (in shares) at Jun. 30, 2023 359,952,112 360,000,000.0        
Ending balance at Jun. 30, 2023 $ 6,644.6 $ 3.6 $ 3,266.5 $ 2,992.9 $ (299.3) $ 680.9